drugset / Trial / NCT05505123

Sevoflurane and Propofol for Botulinum Toxin Injection

NCT05505123 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators would like to compare clinical features (onset, duration, emergence time), efficacy of deep sedation (successful completion of procedure), safety (adverse events) and caregiver's satisfaction for sedation when used propofol and sevoluflurane for deep sedation in 3-11 year old pediatric patients with spastic cerebral palsy receiving botulinum toxin injection.

Timeline

Start
2022-08-26
Primary completion
2022-12-09
Completion
2022-12-09

Outcome

Outcome not reported

Stopped (Enrollment): “No participants enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule — Intravenous
Subject Sevoflurane Other / unclassified — Inhaled

Indications